Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging

[1]  S. Humphries,et al.  In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[3]  R. Tracy.  Inflammation in cardiovascular disease: cart, horse or both--revisited. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[4]  T. Lehtimäki,et al.  Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  R. Virmani,et al.  Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death: Association With Different Pathologies , 2002, Circulation.

[6]  R. Virmani,et al.  Traditional Risk Factors and the Incidence of Sudden Coronary Death With and Without Coronary Thrombosis in Blacks , 2002, Circulation.

[7]  M. Elisaf,et al.  Effects of Fibrates on Serum Metabolic Parameters , 2002, Current medical research and opinion.

[8]  G. Lowe,et al.  Fibrin D-dimer, Markers of Coagulation Activation and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study , 2001, Thrombosis and Haemostasis.

[9]  Paul M. Ridker,et al.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.

[10]  J. Danesh,et al.  Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.

[11]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[12]  P. Sakkinen,et al.  Interleukin-6 exacerbates early atherosclerosis in mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Savage,et al.  The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[14]  M. Litaker,et al.  Effects of physical training and its cessation on the hemostatic system of obese children. , 1999, The American journal of clinical nutrition.

[15]  A. Sharrett,et al.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Litaker,et al.  Fat distribution and hemostatic measures in obese children. , 1998, The American journal of clinical nutrition.

[17]  R. Tracy.  Inflammation in cardiovascular disease: cart, horse, or both? , 1998, Circulation.

[18]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[19]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[20]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[21]  P. Savage,et al.  Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[22]  P. Ridker,et al.  Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.

[23]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[24]  A. Gugliandolo,et al.  Effect of Three Fibrate Derivatives and of Two HMG-CoA Reductase Inhibitors on Plasma Fibrinogen Level in Patients with Primary Hypercholesterolemia , 1993, Thrombosis and Haemostasis.

[25]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.